U. Ripamonti et al., Bone induction by BMPs/OPs and related family members in primates - The critical role of delivery systems, J BONE-AM V, 83A, 2001, pp. S116-S127
Citations number
60
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine","da verificare
Background: In a series of studies in the primate Papio ursinus, we have ex
amined the capacity of bone morphogenetic proteins (BMPs/OPs) delivered in
a variety of biomaterial carrier systems to elicit bone formation in hetero
topic and orthotopic sites. In this review, we compare the osteoinductive e
ffects of different biomaterial delivery systems that have or have not been
pretreated with BMPs/OPs. In particular, we focus on the geometric inducti
on of bone formation by sintered porous hydroxyapatite (SPHA) discs with co
ncavities on their planar surfaces, which elicit bone formation without exo
genously applied BMPs/OPs.
Methods: Heterotopic bone formation was examined by bilaterally implanting
100-mg pellets of a collagenous carrier containing BMPs/OPs in the rectus a
bdominis muscle of the adult baboon. Orthotopic bone formation was examined
by implanting 1 g of a collagenous carrier containing BMPs/OPs into two fu
ll-thickness critical-sized 25-mm-diameter defects on each side of the calv
aria of adult baboons. The BMPs/OPs whose effects were examined included re
combinant human osteogenic protein-1 (rhOP-1), recombinant human transformi
ng growth factor-pr (rhTGF-beta1), rhTGF-beta2, and porcine platelet derive
d transforming growth factor-beta1 (pTGF-beta1). Tissue from the rectus abd
ominis muscle was harvested 30 or 90 days after implantation. Tissue from t
he orthotopic calvarial model was examined at 1, 3, 6, 9, and 12 months aft
er implantation. To demonstrate the effect of surface geometry on bone indu
ction, hydroxyapatite powders were sintered to form solid discs with a seri
es of concavities on the planar surfaces of the SPHA discs. The discs were
either pretreated with exogenous rhOP-1 or not treated with exogenous OF-1.
They were then implanted heterotopically or orthotopically into calvarial
defects. Bone formation was evaluated histologically in undecalcified secti
ons stained with Goldner's trichrome stain or 0.1% toluidine blue.
Results: Naturally derived BMPs/OPs or rhOP-1 in a collagenous carrier elic
it heterotopic bone formation and the complete healing of 25-mm-diameter cr
itical-sized defects by day 90 following implantation. Binary applications
of TGF-beta1 together with rhOP-1 in the collagen carrier induced massive e
ndochondral ossicles in heterotopic sites and bone formation in calvarial d
efects. pTGF-beta1, rhTGF-beta1, and rhTGF-beta2 are powerful inducers of h
eterotopic endochondral bone formation but elicit limited bone formation in
calvarial defects. SPHA discs pretreated with rhOP-1 elicited extensive bo
ne formation in both heterotopic and orthotopic sites. However, SPHA withou
t rhOP-1 also elicited bone formation in heterotopic and orthotopic sites a
nd complete healing of the calvarial defects.
Conclusion: We have prepared SPHA discs with concavities on their planar su
rfaces that induce bone formation in heterotopic or orthotopic critical-siz
ed calvarial defects without exogenously applied BMPs/OPs. This biomaterial
induces bone formation by intrinsic osteoinductivity regulated by the geom
etry of the substratum. The incorporation of specific biological activities
into biomaterials by manipulating the geometry of the substratum, defined
as geometric induction of bone formation, may make it possible to engineer
morphogenetic responses for therapeutic osteogenesis in clinical contexts.
Clinical Relevance: We have implemented a clinical trial using naturally de
rived BMPs/OPs extracted and purified from bovine bone matrices and implant
ed in craniofacial defects in humans. In addition, the discovery that speci
fic geometric and surface characteristics of sintered hydroxyapatites can i
nduce intrinsic osteoinductivity in primates paves the way for formulation
and therapeutic application of porous substrata designed to obtain predicta
ble intrinsic osteoinductivity in clinical contexts.